A team from Shanghai Jiao Tong University and Xinhua Hospital, in China, developed a filter that removes up to 99% of circulating tumor cells from the blood, the cells that can give rise to metastasis. The study was published on November 2, 2026 in Microsystems & Nanoengineering, a journal of the Nature group.
In Mexico, malignant tumors caused 95,362 deaths in 2025 and were the third leading cause of death, according to INEGI statistics released on November 10 and reported by Proceso. The cells that break away from a tumor and travel through the bloodstream can settle in other organs and form new tissue. That process, metastasis, accounts for a large share of cancer deaths. Hence the interest in a tool that seeks to remove those cells before they take hold. El Confidencial described the system as a dialysis machine that returns clean blood to the body.
The device, which its creators called Black hole, uses a pump that draws blood from the carotid artery, passes it through a microfluidic chip with pillars coated in antibodies against the EpCAM protein, and returns it through the jugular vein. In laboratory tests it captured more than 99% of breast cancer cells at low speed, 97.19% of lung cancer cells and 97.42% of prostate cancer cells, according to the study. In mice with breast cancer whose tumor had already been removed, combining the filtering with chemotherapy raised survival to 28 days to 50%, compared with 20% with chemotherapy alone and zero in the untreated group. The work reports a 16.7% reduction in recurrence and a drop in circulating tumor cells from 1,934 to 53. The authors describe the system as a proof of concept.
The filter is not available to patients, according to Investigación y Desarrollo, and it also does not catch tumors without EpCAM, such as glioma, lymphoma or leukemia. Each 30-minute session processed about 0.6 milliliters of blood; cleaning the nearly five liters of an adult requires months of continuous pumping. The next step is testing in rats before considering human trials.
This article was written with the assistance of artificial intelligence from verified sources and reviewed by a human editor before publication.



